Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Exchange Rate Effect (2016 - 2025)

Amphastar Pharmaceuticals has reported Exchange Rate Effect over the past 12 years, most recently at -$9000.0 for Q4 2025.

  • Quarterly results put Exchange Rate Effect at -$9000.0 for Q4 2025, up 18.18% from a year ago — trailing twelve months through Dec 2025 was $210000.0 (up 210.53% YoY), and the annual figure for FY2025 was $210000.0, up 210.53%.
  • Exchange Rate Effect for Q4 2025 was -$9000.0 at Amphastar Pharmaceuticals, up from -$41000.0 in the prior quarter.
  • Over the last five years, Exchange Rate Effect for AMPH hit a ceiling of $142000.0 in Q2 2025 and a floor of -$238000.0 in Q4 2023.
  • Median Exchange Rate Effect over the past 5 years was -$33500.0 (2022), compared with a mean of -$35250.0.
  • Biggest five-year swings in Exchange Rate Effect: crashed 1352.63% in 2023 and later soared 847.37% in 2025.
  • Amphastar Pharmaceuticals' Exchange Rate Effect stood at -$48000.0 in 2021, then surged by 139.58% to $19000.0 in 2022, then crashed by 1352.63% to -$238000.0 in 2023, then skyrocketed by 95.38% to -$11000.0 in 2024, then rose by 18.18% to -$9000.0 in 2025.
  • The last three reported values for Exchange Rate Effect were -$9000.0 (Q4 2025), -$41000.0 (Q3 2025), and $142000.0 (Q2 2025) per Business Quant data.